Navigation Links
Amgen to Present at the Cowen and Company 31st Annual Healthcare Conference
Date:3/3/2011

THOUSAND OAKS, Calif., March 3, 2011 /PRNewswire/ -- Amgen (Nasdaq: AMGN) will present at the Cowen and Company 31st Annual Healthcare Conference on Tuesday, March 8, 2011 at the Boston Marriott Copley Place, Boston, Mass., beginning at 8:45 a.m. Eastern Time.  James Daly, Amgen's Senior Vice President of North American Commercial Operations, will present. Live audio of the presentation can be accessed from the Events Calendar on Amgen's website, www.amgen.com, under Investors.

About AmgenAmgen discovers, develops, manufactures, and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe, effective medicines from lab to manufacturing plant to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, bone disease, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and vital medicines, visit www.amgen.com.CONTACT: Amgen, Thousand OaksDavid Polk, 805-447-4613 (media)Arvind Sood, 805-447-1060 (investors)(Logo:  http://photos.prnewswire.com/prnh/20081015/AMGENLOGO)


'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Amgen Announces Webcast of 2010 Fourth Quarter and Full Year Financial Results
2. Amgen to Acquire BioVex, a Privately Held Biotechnology Company Headquartered in Woburn, Mass
3. Amgen and Xencor Enter Option Deal to Co-Develop Xencors Novel Antibody for Autoimmune Diseases
4. Call for Applications: The Amgen Award for Science Teaching Excellence
5. Amgen Foundation Recognizes Outstanding Staff Volunteers and Contributes $55,000 to Their Favorite Local Nonprofits
6. Amgen to Provide Testimony at FDA Hearing on Biosimilars
7. Amgen Highlights Data to Be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting
8. Amgens Roger M. Perlmutter, M.D., Ph.D., Named 2009 AAAS Fellow, Recognized for Discovery, Development of Novel Medicines
9. Array BioPharma and Amgen Partner in Type 2 Diabetes
10. Amgen to Present at Lazard Capital Healthcare Conference
11. Amgen Announces Webcast of 2009 Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/10/2020)... (PRWEB) , ... March 10, ... ... a full-service cold chain biopharmaceutical engineering firm, is pleased to announce the ... is on combination medical device qualification and validation in the biopharmaceutical cold ...
(Date:3/3/2020)... ... March 03, 2020 , ... ... biotech and medical device industries, was recognized by INC. 5,000 on an annual ... lists to note industry leaders greatly impacting their spheres of influence and experiencing ...
(Date:2/26/2020)... ... February 25, 2020 , ... Continuing ... recently published the results of its safety assessment on the biotechnologically produced 3-Fucolsyllactose ... in human milk. These complex carbohydrates are indigestible and therefore function as a ...
(Date:2/21/2020)... ... 21, 2020 , ... Join Forrest Brown, Engineering Services Manager – Northeast Region ... for an informative session on Wednesday, February 26, 2020 at 1pm EST ... into facility design to add manufacturing flexibility in the future, especially for CMOs , ...
Breaking Biology Technology:
(Date:3/11/2020)... , ... March 11, 2020 , ... ... telemedicine company backed by Siemens Healthineers and several healthcare VC firms introduces a ... 100,000 people in over 100 countries and has caused over 4,000 fatalities to ...
(Date:3/5/2020)... ... March 05, 2020 , ... ... partnership agreement with Phoenestra GmbH to accelerate Cytonus’ existing products and to expand ... Diego, California. Phoenestra is a biotech company located in Austria. , Phoenestra ...
(Date:3/5/2020)... ... March 05, 2020 , ... In September 2016, stem cell ... Test™ is the first, and still only, available technology that provides the cell-specific ... provide information about the number and quality of therapeutic tissue stem cells are ...
Breaking Biology News(10 mins):